{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-064932","form_type":"8-K","ticker":"CHRN","cik":"0001549084","company_name":"EKSO BIONICS HOLDINGS, INC.","filed_at":"2022-05-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.151183+00:00","generated_at":"2026-06-25T06:45:08.225121+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Ekso Bionics CFO Jack Glenn resigns; Controller Jerome Wong named Interim CFO","bullets":["CFO Jack Glenn resigns effective June 17, 2022, to join another public company; no dispute or disagreement.","Jerome Wong, company Controller since May 2017, appointed Interim CFO effective June 17, 2022.","Wong's salary increased from $212,000 to $265,000; target bonus set at 50% of base salary.","Wong to receive RSU award valued at $150,000, vesting over three years from June 17, 2022.","Compensation Committee awards 300,000 RSUs to President & COO Scott Davis for his January 2022 promotion."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-064932","json":"https://secwatch.observer/filing/0001104659-22-064932.json","markdown":"https://secwatch.observer/filing/0001104659-22-064932.md","text":"https://secwatch.observer/filing/0001104659-22-064932.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549084/000110465922064932/0001104659-22-064932-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549084/000110465922064932/tm2216972d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T06:45:08.225121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1258ae2176","claim":"John F. Glenn resigned as Chief Financial Officer at EKSO BIONICS HOLDINGS, INC..","evidence_excerpt":"John F. Glenn notified Ekso Bionics Holdings, Inc. (the “Company”) of his decision to resign from his position as the Company’s Chief Financial Officer, effective June 17, 2022, in connection with his retention as an employee at another public company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1549084/000110465922064932/0001104659-22-064932-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"3023149197","claim":"Jerome Wong was appointed as Interim Chief Financial Officer at EKSO BIONICS HOLDINGS, INC..","evidence_excerpt":"the Company’s board of directors (the “Board”) approved the appointment of Jerome Wong as Interim Chief Financial Officer, effective upon Mr. Glenn’s departure.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1549084/000110465922064932/0001104659-22-064932-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}